Learn about dermatomyositis and the remarkable journey of Audrey Gouskos. Discover how St. Michael's Hospital has provided lifesaving support for her rare disease.

The Crafoord Prize in Polyarthritis 2025, worth 6 million Swedish kronor, is awarded to Christopher Goodnow, Australia, and David Nemazee, USA. They ...

Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational new drug (IND) application to begin ...

Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer and autoimmune disorders. Our goal is to develop and commercialize immune ...

The research could revolutionize therapies for complex conditions like autoimmune disease and cancer. The Tribune, now published from Chandigarh, started publication on February 2, 1881 ...

Rese-cel is a 4-1BB-containing fully human CD19-CAR T cell investigational therapy for patients with autoimmune diseases where B cells contribute to the initiation and/or maintenance of disease.

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases ...

The new biomarkers will enhance the AVISE CTD platform, providing improved clinical utilities for diagnosing autoimmune diseases. The company announced preliminary financial results showing record ...

TED is a debilitating autoimmune disease that affects 70,000 people in the U.S. per year and has a similar prevalence in Europe. The disease is caused by dysfunction in the IGF-1R signaling ...

While the exact cause often remains unknown, factors such as long-term exposure to toxins, infections, autoimmune diseases, or certain medications may contribute to its development. New Delhi ...

The new year is certain to bring the spread of infectious diseases – both new and old. And several factors make 2025 ripe for transmission in the U.S., including declining childhood vaccination ...